Two Sigma Securities’s Accelerate Diagnostics AXDX Stock Holding History

Two Sigma Securities’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18,395	Closed	-$12.9K	–	1500
2025 Q1	$12.9K	Buy	18,395 +1,459	+9%	+$1.66K	﹤0.01%	1182
2024 Q4	$20.3K	Buy	+16,936	New	+$28.1K	﹤0.01%	1316
2022 Q4	–	Sell	-1,513	Closed	-$23K	–	2573
2022 Q3	$23K	Buy	+1,513	New	+$25K	﹤0.01%	2282

Other funds holding AXDX

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Two Sigma Securities's AXDX Position: Q2 2025 in Review

Two Sigma Securities sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 18,395 shares — an estimated $12.9K sold.

Two Sigma Securities first reported a position in AXDX in Q3 2022 and held it in 3 quarters. The position peaked at $23K in Q3 2022. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

Two Sigma Securities reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 18,395 Accelerate Diagnostics shares in Q2 2025, an estimated $12.9K.
Two Sigma Securities first reported a position in Accelerate Diagnostics in Q3 2022 and held it in 3 quarters.
Two Sigma Securities's Accelerate Diagnostics position peaked at $23K in Q3 2022.
3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.